Rockwell Medical, Inc. (Rockwell) is a biopharmaceutical company targeting end-stage renal disease (ESRD) and chronic kidney disease (CKD) with products and services for the treatment of iron deficiency, secondary hyperparathyroidism and hemodialysis. The Company operates through the hemodialysis market segment, which involves the manufacture, sale and distribution of hemodialysis products to hemodialysis clinics, including pharmaceutical, dialysis concentrates, dialysis kits and other ancillary products used in the dialysis process. The Company's drug products include Triferic (ferric pyrophosphate citrate) and Calcitriol (Active Vitamin D) Injection. Triferic is an iron compound that is delivered to hemodialysis patients through dialysate, replacing the iron loss that occurs during their dialysis treatment. Calcitriol (active vitamin D) injection is indicated for treatment of secondary hyperparathyroidism in dialysis patients.
Industry, Sector and Symbol:
- Sector: Medical
- Industry: Specialty & Advanced Pharmaceuticals
- Sub-Industry: Health Care Equipment
- Symbol: NASDAQ:RMTI
- CUSIP: 77437410
- Web: www.rockwellmed.com
Capitalization:- Market Cap: $378.46 million
- Outstanding Shares: 52,057,000
Average Prices:- 50 Day Moving Avg: $7.83
- 200 Day Moving Avg: $6.81
- 52 Week Range: $3.55 - $8.98
P/E:- Trailing P/E Ratio: N/A
- Foreward P/E Ratio: -29.08
- P/E Growth: -0.93
Sales & Book Value:- Annual Revenue: $54.25 million
- Price / Sales: 6.98
- Book Value: $0.97 per share
- Price / Book: 7.49
Profitability:- EBIDTA: ($19,870,000.00)
- Net Margins: -36.35%
- Return on Equity: -36.36%
- Return on Assets: -23.65%
Debt:- Current Ratio: 7.19%
- Quick Ratio: 5.90%
Misc:- Average Volume: 219,675 shs.
- Beta: 2.06
- Short Ratio: 43.76
Frequently Asked Questions for Rockwell Medical (NASDAQ:RMTI)
What is Rockwell Medical's stock symbol?
Rockwell Medical trades on the NASDAQ under the ticker symbol "RMTI."
How were Rockwell Medical's earnings last quarter?
Rockwell Medical, Inc. (NASDAQ:RMTI) announced its quarterly earnings data on Tuesday, May, 9th. The company reported ($0.09) earnings per share for the quarter, meeting analysts' consensus estimates of ($0.09). The company earned $14.60 million during the quarter, compared to analyst estimates of $12.66 million. Rockwell Medical had a negative net margin of 36.35% and a negative return on equity of 36.36%. The firm's revenue for the quarter was up 7.4% on a year-over-year basis. During the same quarter last year, the business posted ($0.10) EPS. View Rockwell Medical's Earnings History.
Where is Rockwell Medical's stock going? Where will Rockwell Medical's stock price be in 2017?
2 analysts have issued 12-month target prices for Rockwell Medical's stock. Their forecasts range from $5.00 to $12.00. On average, they expect Rockwell Medical's stock price to reach $8.50 in the next year. View Analyst Ratings for Rockwell Medical.
Who are some of Rockwell Medical's key competitors?
Some companies that are related to Rockwell Medical include Retrophin (RTRX), Alder BioPharmaceuticals (ALDR), China Cord Blood Corporation (CO), La Jolla Pharmaceutical Company (LJPC), Vanda Pharmaceuticals (VNDA), NeoGenomics (NEO), Revance Therapeutics (RVNC), Enanta Pharmaceuticals (ENTA), Civitas Solutions (CIVI), Heska Corporation (HSKA), Cytokinetics, Incorporated (CYTK), Anika Therapeutics (ANIK), Lantheus Holdings (LNTH), Sangamo Therapeutics (SGMO), Novadaq Technologies (NVDQ), AMAG Pharmaceuticals (AMAG), CRISPR THERAPTC (CRSP) and Depomed (DEPO).
Who are Rockwell Medical's key executives?
Rockwell Medical's management team includes the folowing people:
- Robert L. Chioini, Chairman of the Board, President, Chief Executive Officer
- Thomas E. Klema CPA, MBA, Chief Financial Officer, Vice President, Treasurer, Secretary
- Ajay Gupta M.D., Chief Scientific Officer
- Raymond D. Pratt M.D., Chief Medical Officer
- David Domzalski, Director
- Robin L. Smith M.D., Director
- Patrick J. Bagley, Independent Director
- Ronald D. Boyd, Independent Director
Who owns Rockwell Medical stock?
Rockwell Medical's stock is owned by a number of of retail and institutional investors. Top institutional investors include
RICHMOND BROTHERS, INC.
(10.70%),
RICHMOND BROTHERS, INC.
(10.70%),
RICHMOND BROTHERS, INC.
(10.70%), Creative Planning (0.09%) and Rehmann Capital Advisory Group (0.07%). Company insiders that own Rockwell Medical stock include David S Richmond, Kenneth L Holt, Raymond Dennis Pratt, Robert L Chioini and Ronald D Boyd. View Institutional Ownership Trends for Rockwell Medical.
How do I buy Rockwell Medical stock?
Shares of Rockwell Medical can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Rockwell Medical's stock price today?
One share of Rockwell Medical stock can currently be purchased for approximately $7.27.
MarketBeat Community Rating for Rockwell Medical (NASDAQ RMTI)MarketBeat's community ratings are surveys of what our community members think about Rockwell Medical and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.
Consensus Ratings for Rockwell Medical (NASDAQ:RMTI) (How are Consensus Ratings Calculated?) MarketBeat calculates consensus ratings using the most recent rating from each brokerage that has rated a stock within the last twelve months. Since brokers often use different ratings systems, each rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings. Each stock's consensus rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months.
MarketBeat will no longer include ratings and price target data in its consensus calculation if a broker drops coverage and MarketBeat has received a report that coverage was dropped. Ratings from certain research firms that issue ratings using purely quantitative methods (such as Zacks, Vetr and ValuEngine) are not included in consensus calculations. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
| Ratings Breakdown: | 1 Sell Rating, 1 Buy Rating |
| Consensus Rating: | Hold (Score: 2.00) |
| Consensus Price Target: | $8.50 (16.92% upside) |
Analysts' Ratings History for Rockwell Medical (NASDAQ:RMTI)
Show:
| Date | Firm | Action | Rating | Price Target | Impact on Share Price | Details |
|---|
| 11/9/2016 | BTIG Research | Reiterated Rating | Buy | $12.00 | N/A |  |
| 11/8/2016 | Bank of America Corporation | Downgrade | Neutral -> Underperform | $9.00 -> $5.00 | N/A | |
| 4/6/2016 | Morgan Stanley | Reiterated Rating | Sell | | N/A | |
| 3/1/2016 | Craig Hallum | Downgrade | Buy -> Hold | $7.00 | N/A | |
| 3/1/2016 | Stifel Nicolaus | Downgrade | Buy -> Hold | | N/A | |
| 11/12/2015 | Oppenheimer Holdings, Inc. | Reiterated Rating | Outperform | $26.00 | N/A | |
| 11/11/2015 | Brean Capital | Reiterated Rating | Sell | $4.00 | N/A | |
(Data available from 7/24/2015 forward)
Earnings History for Rockwell Medical (NASDAQ:RMTI)Earnings History by Quarter for Rockwell Medical (NASDAQ RMTI)| Date | Quarter | Consensus Estimate | Actual EPS | Revenue Estimate | Actual Revenue | Release Link | Conference Call | Details |
|---|
| 5/9/2017 | Q1 2017 | ($0.09) | ($0.09) | $12.66 million | $14.60 million | View | Listen | |
| 3/15/2017 | Q4 2016 | ($0.09) | ($0.10) | $15.45 million | $13.39 million | View | N/A | |
| 11/7/2016 | Q3 | ($0.10) | ($0.09) | $15.40 million | $12.81 million | View | Listen | |
| 8/8/2016 | Q2 | ($0.10) | ($0.11) | $13.86 million | $12.50 million | View | N/A | |
| 5/10/2016 | Q1 | ($0.08) | ($0.10) | $15.25 million | $13.63 million | View | Listen | |
| 2/29/2016 | Q4 | $0.02 | ($0.12) | $19.98 million | $14.10 million | View | Listen | |
| 11/9/2015 | Q315 | ($0.02) | ($0.05) | $14.93 million | $14.40 million | View | Listen | |
| 8/4/2015 | Q215 | ($0.10) | ($0.05) | $11.84 million | $12.96 million | View | Listen | |
| 5/7/2015 | Q414 | ($0.10) | ($0.07) | $13.20 million | $13.90 million | View | N/A | |
| 2/26/2015 | Q4 | ($0.10) | ($0.14) | $13.51 million | $14.40 million | View | N/A | |
| 11/10/2014 | Q314 | ($0.10) | ($0.10) | $13.40 million | $13.70 million | View | N/A | |
| 7/31/2014 | Q2 | ($0.13) | ($0.08) | $13.45 million | $13.00 million | View | N/A | |
| 5/12/2014 | Q1 | ($0.14) | ($0.20) | $14.22 million | $13.00 million | View | N/A | |
| 2/26/2014 | | ($0.28) | ($0.21) | | | View | N/A | |
| 11/8/2012 | Q312 | ($0.50) | ($0.86) | $12.57 million | $12.70 million | View | N/A | |
(Data available from 1/1/2011 forward)
Earnings Estimates for Rockwell Medical (NASDAQ:RMTI)| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|
| Q2 2017 | 1 | ($0.10) | ($0.10) | ($0.10) |
| Q3 2017 | 1 | ($0.10) | ($0.10) | ($0.10) |
| Q4 2017 | 1 | ($0.10) | ($0.10) | ($0.10) |
(Data provided by Zacks Investment Research)
Dividend History for Rockwell Medical (NASDAQ:RMTI)
No dividend announcements for this company have been tracked by MarketBeat.com
Insider Trading and Institutional Ownership History for Rockwell Medical (NASDAQ:RMTI)Insider Ownership Percentage: 15.90%
Institutional Ownership Percentage: 20.62%
Insider Trades by Quarter for Rockwell Medical (NASDAQ:RMTI)| Transaction Date | Insider Name | Title | Buy/Sell | Number of Shares | Average Share Price | Total Transaction | Details |
|---|
| 3/22/2017 | David S Richmond | Insider | Buy | 37,210 | $5.84 | $217,306.40 | |
| 3/16/2017 | Kenneth L Holt | Director | Sell | 6,000 | $5.98 | $35,880.00 | |
| 11/11/2016 | Kenneth L Holt | Director | Sell | 19,725 | $5.16 | $101,781.00 | |
| 11/1/2016 | Kenneth L Holt | Director | Sell | 1,400 | $5.92 | $8,288.00 | |
| 10/21/2016 | Kenneth L Holt | Director | Sell | 2,533 | $6.04 | $15,299.32 | |
| 9/19/2016 | Kenneth L Holt | Director | Sell | 8,075 | $6.81 | $54,990.75 | |
| 8/25/2016 | Kenneth L Holt | Director | Sell | 9,520 | $6.37 | $60,642.40 | |
| 8/16/2016 | Kenneth L Holt | Director | Sell | 3,692 | $7.31 | $26,988.52 | |
| 12/4/2015 | Ronald D. Boyd | Director | Sell | 12,500 | $10.58 | $132,250.00 | |
| 8/14/2015 | Robert L Chioini | CEO | Buy | 4,910 | $11.96 | $58,723.60 | |
| 8/13/2015 | Raymond Dennis Pratt | VP | Buy | 5,000 | $11.54 | $57,700.00 | |
| 8/13/2015 | Robert L Chioini | CEO | Buy | 5,090 | $11.51 | $58,585.90 | |
| 8/27/2012 | David A Hagelstein | Major Shareholder | Buy | 7,000 | $8.10 | $56,700.00 | |
(Data available from 1/1/2013 forward)
Headline Trends for Rockwell Medical (NASDAQ:RMTI)
Latest Headlines for Rockwell Medical (NASDAQ:RMTI)
| Source: |
|
| Date | Headline |
|---|
 | Rockwell Medical, Inc. breached its 50 day moving average in a Bearish Manner : RMTI-US : July 18, 2017
finance.yahoo.com - July 19 at 7:20 AM |
 | Zacks Investment Research Upgrades Rockwell Medical, Inc. (RMTI) to Hold
www.americanbankingnews.com - July 12 at 1:02 PM |
 | Rockwell Medical Announces Triferic® Presentation at Annual Conference on Nephrology & Urology July 6-7th, 2017 ... - GlobeNewswire (press release)
globenewswire.com - June 29 at 6:37 AM |
| Rockwell Medical Announces Triferic® Presentation at Annual Conference on Nephrology & Urology July 6-7th, 2017 ... - GlobeNewswire (press release)
globenewswire.com - June 29 at 6:37 AM |
| Rockwell Medical Announces Triferic® Presentation at Annual Conference on Nephrology & Urology July 6-7th, 2017, Kuala Lumpur, Malaysia
finance.yahoo.com - June 28 at 8:39 AM |
| Head-To-Head Contrast: Rockwell Medical (RMTI) & GlaxoSmithKline PLC (GSK)
www.americanbankingnews.com - June 18 at 4:10 PM |
| ETFs with exposure to Rockwell Medical, Inc. : June 15, 2017
finance.yahoo.com - June 16 at 9:26 AM |
| Rockwell Medical (RMTI) & Johnson & Johnson (JNJ) Financial Review
www.americanbankingnews.com - June 10 at 10:10 AM |
 | Rockwell Medical (RMTI) Shareholders Mark H. Ravich Received Support From Over 66% of Votes Cast
www.streetinsider.com - June 7 at 7:36 PM |
| Rockwell Medical (RMTI) Shareholders Mark H. Ravich Received Support From Over 66% of Votes Cast - StreetInsider.com
www.streetinsider.com - June 6 at 9:13 PM |
| Rockwell Medical Shareholders Give Mark H. Ravich Sweeping Mandate for Change
finance.yahoo.com - June 6 at 9:13 PM |
| Rockwell Medical Inc (RMTI) Downgraded to Sell at ValuEngine
www.americanbankingnews.com - June 3 at 12:46 PM |
| Rockwell Medical, Inc. breached its 50 day moving average in a Bearish Manner : RMTI-US : June 2, 2017
finance.yahoo.com - June 2 at 11:06 PM |
 | Rockwell Medical shareholders back Ravich for board seat-sources - Reuters
www.reuters.com - June 2 at 2:57 AM |
 | Shareholders Resoundingly Vote to Support Richmond / Ravich Case for Change at Rockwell Medical - Business Wire (press release)
www.businesswire.com - June 1 at 9:53 PM |
| Rockwell Medical shareholders back Ravich for board seat-sources
finance.yahoo.com - June 1 at 9:53 PM |
| Shareholders Resoundingly Vote to Support Richmond / Ravich Case for Change at Rockwell Medical
finance.yahoo.com - June 1 at 9:53 PM |
| Rockwell Medical loses round in US court in proxy fight - Reuters
www.reuters.com - May 28 at 12:57 AM |
| All Three Major Proxy Advisory Firms Recommend Election of Mark H. Ravich to Rockwell Medical Board
finance.yahoo.com - May 27 at 3:55 AM |
| Court Denies Rockwell’s Motion for Preliminary Injunction against Richmond Brothers and Mark H. Ravich
finance.yahoo.com - May 26 at 6:33 AM |
| Rockwell Medical loses round in U.S. court in proxy fight
finance.yahoo.com - May 26 at 6:33 AM |
| Rockwell Medical Sends Important Message to Richmond Brothers’ Clients: You Have the Sole Authority to Vote Your Own Shares
finance.yahoo.com - May 26 at 6:33 AM |
| Glass Lewis Supports Election of Mark H. Ravich to Rockwell Medical, Inc. Board
finance.yahoo.com - May 24 at 9:44 AM |
| ETFs with exposure to Rockwell Medical, Inc. : May 22, 2017
finance.yahoo.com - May 22 at 6:40 PM |
| ISS Supports Election of Mark H. Ravich to Rockwell Medical, Inc. Board
finance.yahoo.com - May 22 at 9:20 AM |
| Rockwell Medical Issues Letter to Shareholders Explaining Why Electing Mark Ravich Could Do Lasting Harm
finance.yahoo.com - May 22 at 9:20 AM |
| Rockwell Medical Technologies (RMTI) Shareholders Encouraged to Vote Mark Ravich to the Board by Activist ... - StreetInsider.com
www.streetinsider.com - May 20 at 7:05 PM |
| Rockwell Medical Technologies (RMTI) Shareholders Encouraged to Vote Mark Ravich to the Board by Activist Richmond Brothers Inc.
www.streetinsider.com - May 19 at 12:27 PM |
| Richmond Brothers and Mark H. Ravich Issue Letter to Rockwell Medical, Inc. Shareholders
finance.yahoo.com - May 19 at 12:27 PM |
| Rockwell Medical, Inc. :RMTI-US: Earnings Analysis: Q1, 2017 By the Numbers : May 19, 2017
finance.yahoo.com - May 19 at 12:27 PM |
| Rockwell Medical (RMTI) Publishes Shareholder Letter Pushing Back Against Richmond Brothers Inc. Ahead of Annual ... - StreetInsider.com
www.streetinsider.com - May 17 at 5:57 AM |
| Rockwell Medical (RMTI) Publishes Shareholder Letter Pushing Back Against Richmond Brothers Inc. Ahead of Annual Meeting on June 1
www.streetinsider.com - May 16 at 7:28 PM |
| Rockwell Medical, Inc. – Value Analysis (NASDAQ:RMTI) : May 16, 2017
finance.yahoo.com - May 16 at 7:28 PM |
| Rockwell Medical Encourages Shareholders Not to Be Misled by Richmond Brothers
finance.yahoo.com - May 16 at 7:28 PM |
| Richmond Brothers and Mark H. Ravich Issue Presentation Responding to Rockwell Medical’s Misleading and Inaccurate Claims
finance.yahoo.com - May 15 at 9:35 AM |
| Rockwell Medical, Inc. breached its 50 day moving average in a Bearish Manner : RMTI-US : May 15, 2017
finance.yahoo.com - May 15 at 9:35 AM |
| Rockwell Medical Inc Forecasted to Post Q2 2017 Earnings of ($0.10) Per Share (RMTI)
www.americanbankingnews.com - May 15 at 7:28 AM |
| Edited Transcript of RMTI earnings conference call or presentation 9-May-17 8:30pm GMT
finance.yahoo.com - May 10 at 7:47 PM |
| Analysts Anticipate Rockwell Medical Inc (RMTI) to Announce -$0.09 Earnings Per Share
www.americanbankingnews.com - May 10 at 6:14 PM |
 | Rockwell Medical's (RMTI) CEO Rob Chioini on Q1 2017 Results - Earnings Call Transcript - Seeking Alpha
seekingalpha.com - May 10 at 11:11 AM |
| Rockwell Medical Files Investor Presentation - GlobeNewswire (press release)
globenewswire.com - May 10 at 11:11 AM |
| Rockwell Medical Reports First Quarter Results - GlobeNewswire (press release)
globenewswire.com - May 10 at 11:11 AM |
| Rockwell Medical Files Investor Presentation
finance.yahoo.com - May 10 at 11:11 AM |
| Richmond Brothers and Mark H. Ravich Comment on Rockwell Medical, Inc. First Quarter 2017 Earnings
finance.yahoo.com - May 10 at 11:11 AM |
| Rockwell Medical Inc (RMTI) Releases Quarterly Earnings Results, Misses Estimates By $0.01 EPS
www.americanbankingnews.com - May 9 at 9:22 PM |
| Investor Network: Rockwell Medical, Inc. to Host Earnings Call
finance.yahoo.com - May 9 at 7:06 PM |
| Rockwell Medical Reports First Quarter Results
finance.yahoo.com - May 9 at 7:06 PM |
| Rockwell Medical reports 1Q loss
finance.yahoo.com - May 9 at 7:06 PM |
| Rockwell Medical Shareholders Express Support for the Election of David Domzalski
finance.yahoo.com - May 9 at 10:45 AM |
| Rockwell Medical Schedules First Quarter 2017 Earnings Call - GlobeNewswire (press release)
globenewswire.com - May 7 at 8:04 PM |
Rockwell Medical (RMTI) Chart for Monday, July, 24, 2017
